Kim JA - Search Results

1

Design and evaluation of anaplastic lymphoma kinase degraders using a covalent fumarate handle.

Yu N, Lee JE, Park S, Yun SK, Ryu DH, Kim JA, Kim JH, Hwang JY. Yu N, et al. Among authors: kim ja. Bioorg Med Chem Lett. 2024 Dec 15;117:130075. doi: 10.1016/j.bmcl.2024.130075. Online ahead of print. Bioorg Med Chem Lett. 2024. PMID: 39681169 Free article.

2

RNF25 promotes gefitinib resistance in EGFR-mutant NSCLC cells by inducing NF-κB-mediated ERK reactivation.

Cho JH, You YM, Yeom YI, Lee DC, Kim BK, Won M, Cho BC, Kang M, Park S, Yang SJ, Kim JS, Kim JA, Park KC. Cho JH, et al. Among authors: kim ja, kim bk, kim js. Cell Death Dis. 2018 May 22;9(6):587. doi: 10.1038/s41419-018-0651-5. Cell Death Dis. 2018. PMID: 29789542 Free PMC article.

3

Aryl Sulfonamides Induce Degradation of Aryl Hydrocarbon Receptor Nuclear Translocator through CRL4^DCAF15 E3 Ligase.

Kim SA, Jo SH, Cho JH, Yu MY, Shin HC, Kim JA, Park SG, Park BC, Kim S, Kim JH. Kim SA, et al. Among authors: kim s, kim ja, kim jh. Mol Cells. 2020 Nov 30;43(11):935-944. doi: 10.14348/molcells.2020.0122. Mol Cells. 2020. PMID: 33168788 Free PMC article.

4

Long-term depletion of cereblon induces mitochondrial dysfunction in cancer cells.

Park S, Kim K, Haam K, Ban HS, Kim JA, Park BC, Park SG, Kim S, Kim JH. Park S, et al. Among authors: kim s, kim ja, kim k, kim jh. BMB Rep. 2021 Jun;54(6):305-310. doi: 10.5483/BMBRep.2021.54.6.218. BMB Rep. 2021. PMID: 33408001 Free PMC article.

5

Synergistic antitumor activity of sorafenib and MG149 in hepatocellular carcinoma cells.

Moon B, Park M, Cho SH, Kim KM, Seo HR, Kim JH, Kim JA. Moon B, et al. Among authors: kim km, kim ja, kim jh. BMB Rep. 2022 Oct;55(10):506-511. doi: 10.5483/BMBRep.2022.55.10.037. BMB Rep. 2022. PMID: 35880431 Free PMC article.

6

Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells.

Park M, Moon B, Kim JH, Park SJ, Kim SK, Park K, Kim J, Kim SY, Kim JH, Kim JA. Park M, et al. Among authors: kim sy, kim ja, kim sk, kim j, kim jh. Mol Cells. 2022 Aug 31;45(8):550-563. doi: 10.14348/molcells.2022.0009. Epub 2022 Aug 5. Mol Cells. 2022. PMID: 35950456 Free PMC article.

7

Corrigendum to: Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells.

Park M, Moon B, Kim JH, Park SJ, Kim SK, Park K, Kim J, Kim SY, Kim JH, Kim JA. Park M, et al. Among authors: kim sy, kim ja, kim sk, kim j, kim jh. Mol Cells. 2022 Oct 31;45(10):761. doi: 10.14348/molcells.2022.0009.e. Epub 2022 Oct 6. Mol Cells. 2022. PMID: 36254712 Free PMC article. No abstract available.

8

Discovery of pan-IAP degraders via a CRBN recruiting mechanism.

Park S, Kim D, Lee W, Cho JH, Kim S, Lee GS, Moon JH, Kim JA, Ha JD, Kim JH, Kim HJ. Park S, et al. Among authors: kim hj, kim d, kim s, kim ja, kim jh. Eur J Med Chem. 2023 Jan 5;245(Pt 2):114910. doi: 10.1016/j.ejmech.2022.114910. Epub 2022 Nov 9. Eur J Med Chem. 2023. PMID: 36410083

9

CDK9 inhibitors downregulate DKK1 expression to suppress the metastatic potential of HCC cells.

Park M, Cho JH, Moon B, Kim JH, Kim JA. Park M, et al. Among authors: kim ja, kim jh. Genes Genomics. 2023 Mar;45(3):285-293. doi: 10.1007/s13258-022-01351-9. Epub 2023 Jan 20. Genes Genomics. 2023. PMID: 36662391

10

Hypoxia stabilizes SETDB1 to maintain genome stability.

Park S, Cho JH, Kim JH, Park M, Park S, Kim SY, Kim SK, Kim K, Park SG, Park BC, Moon JH, Lee G, Kim S, Kim JA, Kim JH. Park S, et al. Among authors: kim sy, kim s, kim ja, kim sk, kim jh, kim k. Nucleic Acids Res. 2023 Nov 10;51(20):11178-11196. doi: 10.1093/nar/gkad796. Nucleic Acids Res. 2023. PMID: 37850636 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,438 results

Search Page

Filters